122 results
Page 5 of 7
6-K
EX-4.1
0lr p81zu4l3sw
12 May 20
Current report (foreign)
12:04pm
424B5
80fprk1
12 May 20
Prospectus supplement for primary offering
12:02pm
6-K
EX-10.1
ben4d
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-4.1
wayv568i
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
424B5
41s7t6hhiw l4nu7p
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
exe1xlii9s7r6icx96qq
14 Nov 19
Current report (foreign)
7:01am
6-K/A
p0botach3
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
6asrs3g tyc0bw
13 Aug 19
Current report (foreign)
7:00am
S-8
EX-5.1
rs86t
27 Jun 19
Registration of securities for employees
4:06pm
6-K
EX-10.1
a4pep nbo
17 May 19
Current report (foreign)
5:20pm
424B5
18x6x9fkg
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
hmeon
15 May 19
Current report (foreign)
7:00am
6-K
k8ssorsf
20 Nov 18
Current report (foreign)
7:00am
6-K
kxtkd
16 Aug 18
Current report (foreign)
7:00am
424B5
mej9zl 9v7jryoeco7
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-4.1
8dzoumlqziitzyjbifse
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-1.1
a6hrkq6
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
77nqamf4
17 May 18
Current report (foreign)
7:00am